BMI1 and glioblastoma: Targeting oncogenic chromatin repressors such as EZH2 (Enhancer of zeste 2 polycomb repressive complex 2 subunit), BMI-1, and SUZ12, the cooperative strategy of these microRNAs disrupts critical survival mechanisms in glioblastoma cells and unveils promising therapeutic avenues.